Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat. uri icon

Overview

publication date

  • July 21, 2017

Research

keywords

  • Enzyme Inhibitors
  • Glucuronidase
  • Lymphoma
  • Neoplasm Proteins
  • Tumor Microenvironment

Identity

Scopus Document Identifier

  • 85037977501

Digital Object Identifier (DOI)

  • 10.1002/hon.2466

PubMed ID

  • 28730742

Additional Document Info

volume

  • 36

issue

  • 1